Filing
1st Quarter - Report
Bills named in this filing
1
Lobbying activity
3
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation
P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
FY 2026 appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing